20/03/2026 | Webinars

A Case-Based Deep Dive into Challenges, Biomarkers, and Treatment Strategies in the Early Setting

Presented by Dr. Meritxell Bellet Ezquerra, MD, PhD

Dr. Meritxell Bellet Ezquerra is a highly distinguished medical oncologist with over 20 years of dedicated experience in the field of breast cancer.

Invasive Lobular Carcinoma (ILC) represents a distinct biological entity with unique clinical behaviours that often defy the standard "ductal" rules. From diagnostic pitfalls to the complexity of treatment escalation or de-escalation, managing early-stage ILC requires a nuanced approach.

This 30-minute educational session uses a real-world case presentation to navigate the "lobular landscape," focusing on the latest clinical data, biomarker challenges, and the evolving role of chemotherapy..

Why Attend?

While ILC is the second most common type of breast cancer, it remains under-represented in dedicated trials. This session provides a condensed, evidence-based update to help you refine your management strategies for these often-underestimated tumors.

Register now! SECURE YOUR SPOT!

We look forward to seeing you there!